Document is current
Any future updates will be listed below
-
Authors
Renaud, Jennifer M.
Poitrasson-Rivière, Alexis
Moody, Jonathan B.
Hagio, Tomoe
Ficaro, Edward P.
Murthy, Venkatesh L.
- License Information
-
More Information
Article History
Received: 31 May 2023
Accepted: 22 August 2023
First Online: 18 September 2023
Declarations
:
: The retrospective use of these data was approved by the University of Michigan Institutional Review Board.
: Written consent is not required as this study is based on retrospective and anonymized data.
: Not required.
: J.M. Renaud, A. Poitrasson-Riviere, J.B. Moody, and T. Hagio are employees of INVIA Medical Imaging Solutions. J.M. Renaud is a consultant for Jubilant Radiopharma and receives royalties from licensing of FlowQuant software. E.P. Ficaro is an owner and stockholder of INVIA Medical Imaging Solutions, which produces Corridor4DM, a clinical software package for nuclear cardiology analysis. V.L. Murthy is supported by the Melvyn Rubenfire Professorship in Preventive Cardiology. Dr. Murthy has received research grants and speaking honoraria from Siemens Medical Imaging and serves as a scientific advisor for Ionetix and owns stock options in the same. He owns stock in GE and Cardinal Health, has received expert witness payments on behalf of Jubilant DraxImage and a speaking honorarium from 2Quart Medical, and receives both non-financial research support and consulting payments from INVIA.
